GleamWall
中文EN

WHWK Whitehawk Therapeutics, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1422142 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-72.5%
TTM net income YoY67.7%
TTM EPS YoY86.0%
Revenue 3-yr CAGR-22.3%
Net income 3-yr CAGR—

Margins

Gross margin89.4%
Operating margin-1,601.1%
Net margin-288.3%
FCF margin-1,371.4%
EBITDA margin-1,600.0%

Returns

ROE-21.8%
ROA-18.6%
ROIC (approx.)-147.5%
Asset turnover0.06x

Leverage & solvency

Liabilities / assets9.6%
Debt / equity0.00x
Current ratio10.26x
Interest coverage—

Cash quality & payout

Operating cash flow / net income4.73x
Accruals ratio69.5%
Payout ratio—
Capex / revenue7.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$7.14M$25.98M
Cost of revenue$760,000$3.02M
Gross profit$6.38M$22.96M
R&D expense$90.96M$51.03M
SG&A expense$29.82M$36.75M
Operating income-$114.40M-$67.46M
Interest expense$0$154,000
Pretax income-$20.60M-$63.69M
Income tax$0$0
Net income-$20.60M-$63.69M
EBITDA-$114.32M-$67.27M
EPS (basic)-0.33-2.36
EPS (diluted)-0.33-2.36
Weighted avg. shares (diluted)61.89M27.03M
Balance sheet
Cash & equivalents$37.57M$28.67M
Short-term investments$108.13M$18.57M
Receivables$0$5.90M
Inventory$0$5.31M
Current assets$149.01M$61.29M
PP&E, net$3,000$6.85M
Total assets$150.83M$70.32M
Current liabilities$14.52M$17.07M
Total liabilities$14.52M$17.84M
Shareholders' equity$136.31M$52.48M
Shares outstanding47.15M24.68M
Cash flow statement
Operating cash flow-$97.43M-$59.55M
Capital expenditure$552,000$1.65M
Free cash flow-$97.98M-$61.20M
Investing cash flow$11.89M$25.20M
Financing cash flow$94.38M$130,000
Depreciation & amortization$79,000$193,000
Stock-based compensation$9.87M$10.84M

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.